8-Bromo Cyclic Adenosine Monophosphate
"8-Bromo Cyclic Adenosine Monophosphate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A long-acting derivative of cyclic AMP. It is an activator of cyclic AMP-dependent protein kinase, but resistant to degradation by cyclic AMP phosphodiesterase.
| Descriptor ID |
D015124
|
| MeSH Number(s) |
D03.633.100.759.646.138.395.225 D13.695.462.200.225 D13.695.667.138.395.225 D13.695.827.068.395.225
|
| Concept/Terms |
8-Bromo Cyclic Adenosine Monophosphate- 8-Bromo Cyclic Adenosine Monophosphate
- 8 Bromo Cyclic Adenosine Monophosphate
- Br Cycl AMP
- AMP, Br Cycl
- 8-Bromo-cAMP
- 8 Bromo cAMP
- 8-Bromoadenosine 3',5'-Cyclic Monophosphate
- 8 Bromoadenosine 3',5' Cyclic Monophosphate
- 8-Br Cyclic AMP
- 8 Br Cyclic AMP
- Cyclic AMP, 8-Br
- 8-Bromo Cyclic AMP
- 8 Bromo Cyclic AMP
- Cyclic AMP, 8-Bromo
|
Below are MeSH descriptors whose meaning is more general than "8-Bromo Cyclic Adenosine Monophosphate".
Below are MeSH descriptors whose meaning is more specific than "8-Bromo Cyclic Adenosine Monophosphate".
This graph shows the total number of publications written about "8-Bromo Cyclic Adenosine Monophosphate" by people in this website by year, and whether "8-Bromo Cyclic Adenosine Monophosphate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "8-Bromo Cyclic Adenosine Monophosphate" by people in Profiles.
-
Expression of CCAAT/enhancer binding proteins alpha and beta in the porcine ovary and regulation in primary cultures of granulosa cells. Biol Reprod. 2005 May; 72(5):1194-204.
-
Cyclic AMP inhibits production of interleukin-6 and migration in human vascular smooth muscle cells. J Surg Res. 2003 Jan; 109(1):57-61.
-
N-Methyl-D-aspartate receptors and p38 mitogen-activated protein kinase are required for cAMP-dependent cyclase response element binding protein and Elk-1 phosphorylation in the striatum. Neuroscience. 2000; 101(3):607-17.
-
Therapy for X-adrenoleukodystrophy: normalization of very long chain fatty acids and inhibition of induction of cytokines by cAMP. J Lipid Res. 1998 May; 39(5):1091-100.
-
Agonists and antagonists differentially regulate the high affinity state of the D2L receptor in human embryonic kidney 293 cells. Mol Pharmacol. 1995 Nov; 48(5):956-64.
-
Paradoxical regulation of dopamine receptors in transfected 293 cells. Mol Pharmacol. 1993 Aug; 44(2):371-9.